A temperature excursion in a pharmaceutical distribution operation is not a quality event that can be handled on Monday morning if it happens on a Friday afternoon. It is a deviation with a defined regulatory response requirement, a product disposition decision that carries patient safety consequences, and an inspection finding in waiting if the documentation trail does not hold up. The first 24 hours after a temperature excursion is detected define everything that comes after: whether the product is correctly quarantined, whether the investigation reaches a defensible root cause, whether the manufacturer is notified in time to provide a usability assessment, and whether your QMS can demonstrate to an MHRA inspector that your organisation genuinely controls its cold chain rather than simply monitors it.
Recent MHRA inspection trends consistently flag temperature excursion documentation as one of the most recurring GDP deficiency categories. The issue is rarely that companies have no monitoring systems. It is that their response to what those systems detect is not structured, not documented in time, and not connected to a genuine quality investigation. This blog sets out what a compliant, inspection-ready response looks like, hour by hour, across the first 24 hours.
Understanding What A Temperature Excursion Actually Is
A temperature excursion is any deviation from a pharmaceutical product’s specified temperature range during storage, transport, or handling, as determined by the manufacturer’s stability data and regulatory requirements. This definition matters because the specification is product-specific, not generic. A 2-8°C refrigerated product that reaches 9°C for 40 minutes during loading is an excursion against one product’s specification. Whether that excursion compromises the product depends entirely on that product’s stability profile, not a general industry rule of thumb.
The MHRA and EU GDP Guidelines (2013/C 343/01) require wholesale dealers to differentiate between excursion types based on severity, duration, and product risk:
- Minor excursions: brief temperature deviations during authorised operational activity such as loading or unloading, within a short and documented window
- Significant excursions: deviations that exceed the product’s stability specification window, affect large quantities, or involve high-risk product categories such as biologics, vaccines, ATMPs, or temperature-sensitive controlled drugs
- Critical excursions: cold chain breaks of extended duration, complete monitoring failures, or events affecting products where any exposure outside the specified range renders the product unusable
Both minor and critical excursions require formal documentation and investigation. Neither can be handled informally. As the MHRA’s GMP and GDP guidance on GOV.UK states, significant deviations must be formally investigated, reported, and resolved through documented CAPA processes with evidence of implementation.
Hour Zero To Four: Detect, Quarantine, And Notify
The moment a temperature alarm is triggered or an excursion is identified from a data logger, the clock starts. The first actions are not investigative. They are containment. Nothing that follows is credible if the affected product was not isolated from releasable stock at the point of detection.
Immediate actions in the first four hours:
- Place all potentially affected products into quarantine status without delay. Physical quarantine in a segregated area with clear labelling must happen simultaneously with system quarantine in the inventory management or WMS system. Products in quarantine must not be released, transferred, or supplied until a formal disposition decision has been made and documented.
- Retrieve the full temperature data log from the monitoring device. Calibrated data loggers or continuous electronic monitoring systems must provide time-stamped records covering the minimum and maximum temperatures reached and the duration of the excursion.
- Record the exact time and circumstances of detection. Who identified the excursion? What system generated the alert? What time was it detected, and what is the estimated time the excursion began? This timeline becomes a permanent part of the deviation record.
- Notify the Responsible Person immediately. Not at the end of the shift. The RP must be informed as soon as the excursion is identified, and their documented involvement from the outset is a GDP requirement, not an operational preference.
- Notify the Licence Holder or senior management if the excursion involves high-risk product categories, extended duration, or any indication of systemic equipment failure.
- Do not attempt to assess product usability at this stage. That decision requires stability data and, in most cases, manufacturer input. The purpose of the first four hours is containment and documentation initiation only.
Hour Four To Twelve: Open The Deviation And Gather All Data
Once quarantine is in place and the RP is informed, the formal deviation process must be opened. Under GDP, a temperature excursion is a quality event requiring a documented deviation record regardless of whether the product is ultimately found to be unaffected.
The deviation record must capture all of the following:
- Product name, batch number, quantity, and applicable temperature storage requirement
- Full temperature history during the excursion period, including minimum and maximum recorded temperatures, excursion duration, and the time normal conditions were restored
- The storage unit, vehicle, or transit leg where the excursion occurred
- Conditions at the time of the event, including ambient temperature, equipment status, door access records, and any operational activities that may have contributed
- The name of the person who identified the excursion and the documented time of RP notification
This is also the point at which the manufacturer or Marketing Authorisation Holder must be contacted. GDP places responsibility on the wholesale dealer to notify the MAH when an excursion has occurred, so the manufacturer can formally assess whether the product remains within its stability specification. This request must be made in writing, and the manufacturer’s written response must be retained as part of the deviation record.
Contacting the manufacturer must happen in parallel with the early stages of the investigation, not after it is complete. Delays in notifying manufacturers are themselves a GDP gap that MHRA inspectors will identify and cite.
Hour Twelve To Twenty-Four: Impact Assessment, Root Cause, And Capa Initiation
By the midpoint of the first 24 hours, the investigation moves from data collection to analysis. Two workstreams run in parallel from this point: the product impact assessment and the root cause investigation.
The product impact assessment uses:
- The temperature data log from the monitoring device
- The product’s manufacturer-approved stability profile and allowable excursion limits
- The manufacturer’s written assessment in response to your notification
- Mean Kinetic Temperature (MKT) calculation where applicable, a scientifically established metric referenced in ICH Q1A that accounts for cumulative thermal stress on the product over time rather than simply identifying whether a peak was reached
Based on the impact assessment, a formal disposition decision must be made and documented:
- Release: the excursion is confirmed to have no impact on product quality; the product may be released from quarantine with documented justification
- Quarantine pending further testing: the data is insufficient for a clear release decision; additional testing, further stability review, or additional manufacturer input is required before disposition can be made
- Reject and destroy: the excursion is assessed as having compromised product quality; the product must be formally rejected, removed from the supply chain, and destroyed through documented procedures with records retained
The root cause investigation runs in parallel and should involve all relevant functions. Root cause analysis tools such as 5 Whys or FMEA are appropriate here. The investigation must determine whether the excursion was:
- Equipment-related: a sensor failure, refrigeration unit malfunction, calibration lapse, or vehicle breakdown
- Process-related: a door left open during loading, an inadequate cool-down period, or an SOP not followed correctly
- Systemic: a recurring pattern that has not been addressed in previous CAPAs, indicating a quality system control failure rather than an isolated event
The distinction between equipment fault and systemic failure matters because a maintenance job formatted as a CAPA is not a root cause investigation. MHRA inspectors recognise this consistently.
By the end of the first 24 hours, your deviation record must contain:
- The full temperature data and a clear record of when the excursion was detected
- Documented quarantine actions with timestamps
- The manufacturer notification and any response received
- The initiation of the impact assessment with interim findings
- The opening of the root cause investigation
- CAPA initiated with corrective containment actions documented and a clear timeline for preventive action completion
How Quality Vigilance Ltd Can Help
Temperature excursion management is one of the most consistently inspected areas of GDP compliance, and the gap between those who handle it correctly and those who do not almost always appears in documentation quality rather than monitoring technology. Quality Vigilance Ltd works with wholesale dealers, importers, and distribution operations across the following specific areas:
- Reviewing and rewriting temperature excursion SOPs to meet current MHRA inspection expectations, covering escalation timelines, quarantine procedures, manufacturer notification requirements, and disposition decision criteria
- Conducting gap assessments of historical deviation records to identify whether past excursion events were investigated to the correct depth and whether previous CAPAs addressed root causes or symptoms
- Supporting live excursion investigations where experienced regulatory input is needed for impact assessment and root cause analysis, particularly for high-value or high-risk product categories
- Preparing CAPA documentation to a standard that will withstand MHRA scrutiny, with defined effectiveness checks and closure criteria
- Advising on temperature mapping requirements for storage facilities and transport lanes, including seasonal variation mapping and qualification protocols aligned with current MHRA expectations
- Supporting inspection readiness reviews focused specifically on the cold chain documentation trail, including data logger calibration records, excursion histories, manufacturer communication logs, and product disposition records
For organisations that have already received MHRA findings related to temperature control, Quality Vigilance provides structured remediation support covering both the CAPA response and re-inspection preparation to close findings on evidence rather than promises.
Visit qualityvigilance.com or contact the team at [email protected] to discuss your cold chain compliance position.